| More |
Deliverable Number
|
Commodity/Service Type
|
Major Deliverable
|
Method of Payment
|
|
|
1
|
Biomedical research services
|
The Grantee will provide the Department with valuable research data with the goals of improving the ...
|
Fixed Price - Lump Sum
|
| Major Deliverable: The Grantee will provide the Department with valuable research data with the goals of improving the health of Floridians by researching better prevention and diagnoses of and treatments and cures for Alzheimer’s disease; expanding the foundation of knowledge relating to the prevention, diagnosis, treatment, and cure of Alzheimer’s disease; stimulating economic activity in the state in areas related to Alzheimer’s disease research.
FY16/17: Quarterly narrative research progress reports, financial reports and the deliverables as outlined in Attachment 2 on the research project entitled, Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease for the purposes of accountability and compilation of valuable data required for reporting to the Legislature and Governor pursuant to section 381.82(4), Florida Statutes (F.S.).
Qtr. 3: $5,882.00
Qtr. 4: $5,882.00
|
| Deliverable Price: $11,764.00 |
| Non Price Justification: |
| Performance Metrics: 100% of the following reports completed according to deadline stated: Quarterly narrative research progress summary report, quarterly financial report, quarterly expenditure summary report and quarterly invoice. |
| Financial Consequences: Failure to comply with all deliverables required shall result in financial consequences of ten percent per invoice or grant termination. |
| Source Documentation Page Reference: |
| Deliverable Number: 1 |
|
|
|
2
|
Biomedical research services
|
The Grantee will provide the Department with valuable research data with the goals of improving the ...
|
Fixed Price - Lump Sum
|
| Major Deliverable: The Grantee will provide the Department with valuable research data with the goals of improving the health of Floridians by researching better prevention and diagnoses of and treatments and cures for Alzheimer’s disease; expanding the foundation of knowledge relating to the prevention, diagnosis, treatment, and cure of Alzheimer’s disease; stimulating economic activity in the state in areas related to Alzheimer’s disease research.
FY17/18: Quarterly narrative research progress reports, financial reports and the deliverables as outlined in Attachment 2 on the research project entitled, Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease for the purposes of accountability and compilation of valuable data required for reporting to the Legislature and Governor pursuant to section 381.82(4), Florida Statutes (F.S.).
Qtr. 1: $5,882.00
Qtr. 2: $5,882.00
Qtr. 3: $5,882.00
Qtr. 4: $5,882.00
|
| Deliverable Price: $23,528.00 |
| Non Price Justification: |
| Performance Metrics: 100% of the following reports completed according to deadline stated: Quarterly narrative research progress summary report, quarterly financial report, quarterly expenditure summary report and quarterly invoice. |
| Financial Consequences: Failure to comply with all deliverables required shall result in financial consequences of ten percent per invoice or grant termination. |
| Source Documentation Page Reference: |
| Deliverable Number: 2 |
|
|
|
3
|
Biomedical research services
|
The Grantee will provide the Department with valuable research data with the goals of improving the ...
|
Fixed Price - Lump Sum
|
| Major Deliverable: The Grantee will provide the Department with valuable research data with the goals of improving the health of Floridians by researching better prevention and diagnoses of and treatments and cures for Alzheimer’s disease; expanding the foundation of knowledge relating to the prevention, diagnosis, treatment, and cure of Alzheimer’s disease; stimulating economic activity in the state in areas related to Alzheimer’s disease research.
FY18/19: Quarterly narrative research progress reports, financial reports and the deliverables as outlined in Attachment 2 on the research project entitled, Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease for the purposes of accountability and compilation of valuable data required for reporting to the Legislature and Governor pursuant to section 381.82(4), Florida Statutes (F.S.).
Qtr. 1: $5,882.00
Qtr. 2: $5,882.00
Qtr. 3: $5,882.00
Qtr. 4: $5,882.00
|
| Deliverable Price: $23,528.00 |
| Non Price Justification: |
| Performance Metrics: 100% of the following reports completed according to deadline stated: Quarterly narrative research progress summary report, quarterly financial report, quarterly expenditure summary report and quarterly invoice. |
| Financial Consequences: Failure to comply with all deliverables required shall result in financial consequences of ten percent per invoice or grant termination. |
| Source Documentation Page Reference: |
| Deliverable Number: 3 |
|
|
|
4
|
Biomedical research services
|
The Grantee will provide the Department with valuable research data with the goals of improving the ...
|
Fixed Price - Lump Sum
|
| Major Deliverable: The Grantee will provide the Department with valuable research data with the goals of improving the health of Floridians by researching better prevention and diagnoses of and treatments and cures for Alzheimer’s disease; expanding the foundation of knowledge relating to the prevention, diagnosis, treatment, and cure of Alzheimer’s disease; stimulating economic activity in the state in areas related to Alzheimer’s disease research.
FY19/20: Quarterly narrative research progress reports, financial reports and the deliverables as outlined in Attachment 2 on the research project entitled, Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease for the purposes of accountability and compilation of valuable data required for reporting to the Legislature and Governor pursuant to section 381.82(4), Florida Statutes (F.S.).
Qtr. 1: $5,882.00
Qtr. 2: $5,882.00
Qtr. 3: $5,882.00
Qtr. 4: $5,882.00
|
| Deliverable Price: $23,528.00 |
| Non Price Justification: |
| Performance Metrics: 100% of the following reports completed according to deadline stated: Quarterly narrative research progress summary report, quarterly financial report, quarterly expenditure summary report and quarterly invoice. |
| Financial Consequences: Failure to comply with all deliverables required shall result in financial consequences of ten percent per invoice or grant termination. |
| Source Documentation Page Reference: |
| Deliverable Number: 4 |
|
|
|
5
|
Biomedical research services
|
The Grantee will provide the Department with valuable research data with the goals of improving the ...
|
Fixed Price - Lump Sum
|
| Major Deliverable: The Grantee will provide the Department with valuable research data with the goals of improving the health of Floridians by researching better prevention and diagnoses of and treatments and cures for Alzheimer’s disease; expanding the foundation of knowledge relating to the prevention, diagnosis, treatment, and cure of Alzheimer’s disease; stimulating economic activity in the state in areas related to Alzheimer’s disease research.
FY20/21: Quarterly narrative research progress reports, financial reports and the deliverables as outlined in Attachment 2 on the research project entitled, Antibody targeting of IL1RAP and studying their therapeutic effects in mouse models of Alzheimer’s disease for the purposes of accountability and compilation of valuable data required for reporting to the Legislature and Governor pursuant to section 381.82(4), Florida Statutes (F.S.).
Qtr. 1: $5,882.00
Qtr. 2: $5,882.00
Qtr. 3: $5,888.00
|
| Deliverable Price: $17,652.00 |
| Non Price Justification: |
| Performance Metrics: 100% of the following reports completed according to deadline stated: Quarterly narrative research progress summary report, quarterly financial report, quarterly expenditure summary report and quarterly invoice. |
| Financial Consequences: Failure to comply with all deliverables required shall result in financial consequences of ten percent per invoice or grant termination. |
| Source Documentation Page Reference: |
| Deliverable Number: 5 |
|